Neutrophil–Lymphocyte Ratio Connected to Treatment Options and Inflammation Markers of Ankylosing Spondylitis

E-ISSN： 1098-2825|29|4|294-298

ISSN： 0887-8013

Source： Journal Of Clinical Laboratory Analysis (Electronic), Vol.29, Iss.4, 2015-07, pp. : 294-298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Etoricoxib and the treatment of ankylosing spondylitis

By Lories Rik J

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 12, 2012-12 ,pp. : 1599-1608

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab for the treatment of ankylosing spondylitis

By Sieper Joachim Rudwaleit Martin Braun Jürgen

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 831-838

Informa Healthcare

Access to resources Recommend Favorite

Recent progress in ankylosing spondylitis treatment

By Toussirot Éric Wendling Daniel

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 1, 2003-01 ,pp. : 1-12

Informa Healthcare

Access to resources Recommend Favorite

The safety of celecoxib in ankylosing spondylitis treatment

By Poddubnyy Denis A Song In-Ho Sieper Joachim

Expert Opinion on Drug Safety, Vol. 7, Iss. 4, 2008-07 ,pp. : 401-409

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Ankylosing Spondylitis with Biologic Agents

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 9, Iss. 1, 2010-03 ,pp. : 35-40

Bentham Science Publishers

Access to resources Recommend Favorite